| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/HUM.2007.147 |
| P8608 | Fatcat ID | release_mkly45uyfjf45d3fh6p3xsetdq |
| P932 | PMC publication ID | 2760384 |
| P698 | PubMed publication ID | 18092919 |
| P5875 | ResearchGate publication ID | 5756016 |
| P2093 | author name string | Rebecca T Marquez | |
| Anton P McCaffrey | |||
| P2860 | cites work | microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder | Q21184126 |
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins | Q40589574 | ||
| Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs | Q41843084 | ||
| A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice | Q43919575 | ||
| Immune response to green fluorescent protein: implications for gene therapy | Q45861644 | ||
| AAV vector integration sites in mouse hepatocellular carcinoma. | Q45869780 | ||
| Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus | Q48266570 | ||
| Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. | Q51958786 | ||
| LNA-modified oligonucleotides mediate specific inhibition of microRNA function. | Q52665239 | ||
| Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia | Q57234164 | ||
| Humoral immune response in mice against a circulating antigen induced by adenoviral transfer is strictly dependent on expression in antigen-presenting cells | Q64378303 | ||
| A protocol for designing siRNAs with high functionality and specificity | Q81246968 | ||
| Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA | Q81340909 | ||
| miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
| Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes | Q24537363 | ||
| Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing | Q24537549 | ||
| Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
| Improved targeting of miRNA with antisense oligonucleotides | Q24547511 | ||
| Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells | Q24555724 | ||
| Accumulation of miR-155 and BIC RNA in human B cell lymphomas | Q24556523 | ||
| MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B | Q24564757 | ||
| Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
| A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure | Q24673535 | ||
| Sequence-specific inhibition of small RNA function | Q24797869 | ||
| Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis | Q24798477 | ||
| An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi | Q24806293 | ||
| siRNA-mediated off-target gene silencing triggered by a 7 nt complementation | Q24812419 | ||
| Real-time expression profiling of microRNA precursors in human cancer cell lines | Q24817136 | ||
| Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed | Q25257225 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| A microRNA polycistron as a potential human oncogene | Q27860720 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| Identification of novel genes coding for small expressed RNAs | Q27860917 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs | Q27861053 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells | Q28207586 | ||
| Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation | Q28236026 | ||
| High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma | Q28236173 | ||
| Target mimicry provides a new mechanism for regulation of microRNA activity | Q28237268 | ||
| The let-7 microRNA represses cell proliferation pathways in human cells | Q28240833 | ||
| Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript | Q28243242 | ||
| MicroRNA signatures in human ovarian cancer | Q28249211 | ||
| Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells | Q28249223 | ||
| Antisense-mediated depletion reveals essential and specific functions of microRNAs in Drosophila development | Q28259235 | ||
| Identification of virus-encoded microRNAs | Q28259309 | ||
| MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
| Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
| The diverse functions of microRNAs in animal development and disease | Q28266193 | ||
| Sequence variants in SLITRK1 are associated with Tourette's syndrome | Q28276961 | ||
| A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia | Q28279141 | ||
| A pancreatic islet-specific microRNA regulates insulin secretion | Q28292726 | ||
| Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines | Q28975767 | ||
| The widespread impact of mammalian MicroRNAs on mRNA repression and evolution | Q29547173 | ||
| miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting | Q29547487 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| A brain-specific microRNA regulates dendritic spine development | Q29614753 | ||
| A cellular microRNA mediates antiviral defense in human cells | Q29615828 | ||
| Expression profiling reveals off-target gene regulation by RNAi | Q29615965 | ||
| MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 | ||
| miR-21-mediated tumor growth | Q29616149 | ||
| Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3'UTR evolution | Q29616370 | ||
| Identification of microRNAs of the herpesvirus family | Q29618671 | ||
| MicroRNA-143 regulates adipocyte differentiation | Q29619164 | ||
| An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues | Q29619171 | ||
| Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice | Q29619279 | ||
| BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas | Q29622911 | ||
| Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1. | Q30831276 | ||
| Developmental defects by antisense-mediated inactivation of micro-RNAs 2 and 13 in Drosophila and the identification of putative target genes | Q31154516 | ||
| Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus | Q33883910 | ||
| Gene silencing using micro-RNA designed hairpins | Q34364532 | ||
| Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? | Q34455538 | ||
| Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells | Q34460403 | ||
| 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets | Q34496075 | ||
| Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer | Q34516810 | ||
| Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways | Q34530552 | ||
| SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells | Q34558129 | ||
| Expression profiling identifies microRNA signature in pancreatic cancer | Q34588109 | ||
| Prediction and identification of herpes simplex virus 1-encoded microRNAs | Q34648394 | ||
| Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript | Q35024058 | ||
| Progress and problems with the use of viral vectors for gene therapy | Q35120176 | ||
| Specificity, duplex degradation and subcellular localization of antagomirs | Q35837407 | ||
| Cloning and analysis of microRNAs encoded by the primate gamma-herpesvirus rhesus monkey rhadinovirus | Q35928663 | ||
| Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC | Q35990922 | ||
| Unconventional processing of the 3' termini of the Epstein-Barr virus DNA polymerase mRNA. | Q36050825 | ||
| MicroRNAs in vertebrate development | Q36175229 | ||
| Gene transfer for hemophilia: can therapeutic efficacy in large animals be safely translated to patients? | Q36230845 | ||
| MicroRNAs and viral infection | Q36279196 | ||
| MicroRNAs: a new class of regulatory genes affecting metabolism | Q36524940 | ||
| Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells | Q36603910 | ||
| Expression and function of microRNAs in viruses great and small | Q36768152 | ||
| DNA methyltransferase inhibitors for cancer therapy | Q36803702 | ||
| MicroRNAs in viral replication and pathogenesis | Q36804732 | ||
| Argonaute proteins: mediators of RNA silencing | Q36845844 | ||
| Silencing of CXCR4 blocks breast cancer metastasis | Q37074006 | ||
| Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis | Q37596477 | ||
| MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). | Q38303663 | ||
| Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway | Q38504286 | ||
| Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis | Q40250297 | ||
| Suppression of RNA interference by adenovirus virus-associated RNA. | Q40398056 | ||
| Regulation of human immunodeficiency virus 1 transcription by nef microRNA. | Q40456215 | ||
| Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. | Q40543795 | ||
| P433 | issue | 1 | |
| P921 | main subject | microRNA | Q310899 |
| P304 | page(s) | 27-38 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Human Gene Therapy | Q15757580 |
| P1476 | title | Advances in microRNAs: implications for gene therapists | |
| P478 | volume | 19 |
| Q33787568 | A miR-21 hairpin structure-based gene knockdown vector |
| Q39513204 | Creating a flexible multiple microRNA expression vector by linking precursor microRNAs |
| Q56688688 | Differentially expressed microRNA in multiple sclerosis: A window into pathogenesis? |
| Q42555042 | Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon |
| Q37413629 | Evaluation of miR-122-regulated suicide gene therapy for hepatocellular carcinoma in an orthotopic mouse model |
| Q28291186 | FGF receptors: cancer biology and therapeutics |
| Q30377044 | Formulation of New Algorithmics for miRNAs |
| Q33388163 | Forward and robust selection of the most potent and noncellular toxic siRNAs from RNAi libraries |
| Q26744842 | Investigative and extrapolative role of microRNAs' genetic expression in breast carcinoma |
| Q36940126 | Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver |
| Q34008355 | MicroRNA 21 blocks apoptosis in mouse periovulatory granulosa cells |
| Q37962000 | MicroRNA dysregulation during chemical carcinogenesis |
| Q37135817 | MicroRNA: An emerging therapeutic target and intervention tool |
| Q41974673 | MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression. |
| Q37801839 | Physiological and tissue-specific vectors for treatment of inherited diseases |
| Q21245112 | Selective gene silencing by viral delivery of short hairpin RNA |
| Q42269889 | Targeting MYC-Regulated miRNAs to Combat Cancer |
| Q37416211 | Toll gates to periodontal host modulation and vaccine therapy |
| Q35110219 | Variables and strategies in development of therapeutic post-transcriptional gene silencing agents |
| Q83308550 | [Molecular pathology as an necessity: its role in diagnostic and predictive pathology] |
| Q24619682 | miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo |
| Q38092617 | miRNA-Based Therapeutic Strategies |
Search more.